Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-14-022787
Filing Date
2014-05-23
Accepted
2014-05-23 11:36:27
Documents
1
Period of Report
2014-05-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 6326
  Complete submission text file 0001140361-14-022787.txt   7654
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2273 RESEARCH BLVD. SUITE 400 ROCKVILLE MD 20850
Business Address
Niederhuber John (Reporting) CIK: 0001501240 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33137 | Film No.: 14866107